Can shrinking tumors before surgery improve robotic lung cancer outcomes?

NCT ID NCT07528066

Recruiting now Knowledge-focused Sponsor: Shanghai Chest Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study enrolls 200 people with stage IIB-III non-small cell lung cancer who receive chemo-immunotherapy before robotic surgery. Researchers want to see if tumor and lymph node shrinkage (downstaging) leads to better surgical results, like complete tumor removal and fewer complications. Participants are followed from multiple international centers to collect data on surgery and recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors predict which lung cancer patients will have the best surgical outcomes after chemo-immunotherapy.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all patients or change current practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOADJUVANT CHEMOIMMUNOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOADJUVANT CHEMOIMMUNOTHERAPY ROBOTIC PULMONARY RESECTION STAGE IIB-III NSCLC

Contacts and locations

Locations

Azienda Ospedaliera di Cosenza
RECRUITING

Cosenza, 87100, Italy
Fujian Medical University Union Hospital
RECRUITING

Fuzhou, Fujian, 350001, China
Guangdong Provincial People's Hospital
RECRUITING

Guangzhou, Guangdong, 510080, China
Hôpital Saint Joseph Marseille
RECRUITING

Marseille, 13001, France
Jiangsu Cancer Institute & Hospital
RECRUITING

Nanjing, Jiangsu, 210009, China
Shanghai Chest Hospital, Shanghai Jiao Tong University Medicine of School
RECRUITING

Shanghai, 200030, China
Shenzhen People's Hospital
RECRUITING

Shenzhen, Guangdong, 518020, China
The Affiliated Hospital of Qingdao University
RECRUITING

Qingdao, Shandong, 266000, China
Tianjin Medical University Cancer Institute & Hospital
RECRUITING

Tianjing, Tianjing, 300060, China
University Hospital, Rouen
RECRUITING

Rouen, 76000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.